Yucca Health Tirzepatide Review: Cost, the New-Patient Rate & Honest Verdict (2026)

Yucca Health competes on price for compounded semaglutide and tirzepatide across all 50 states. The published $258 figure carries two qualifiers that matter more than the number itself: it's a new-patient, first-order rate, and it's quoted on a six-month plan — what you pay from the second order onward is disclosed only after you complete intake. Every fact here comes from the company's own published program.

What Yucca Health is

Yucca Health is a telehealth provider competing on price for compounded semaglutide and tirzepatide, available in all 50 states. There is very little published detail on clinicians, pharmacies, or program structure beyond the pricing itself.

The $258 figure, and why it's not what it looks like

Yucca Health's advertised $258/month price, comes with two qualifiers worth reading before comparing it to a competitor's headline: it's a new-patient, first-order rate, and it's quoted specifically on a six-month plan. The ongoing rate from the second order onward is not published anywhere and is disclosed only after you've completed the intake process — making the headline figure genuinely hard to compare against a provider that quotes a standing monthly rate up front.

The brand-vs-compounded question

Yucca Health dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Yucca Health's real strengths: availability in all 50 states, and both compounded semaglutide and tirzepatide offered. The trade-offs: the $258 price is a new-patient, first-order figure on a six-month plan, not a standing monthly rate; the ongoing price is undisclosed until after intake; and this review found very little published information about the program's clinicians, pharmacy partners, or overall structure. As with any GLP-1 program, get the ongoing monthly rate in writing before you commit to a six-month plan; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Yucca Health's $258 headline is real but genuinely hard to compare — it's a first-order, six-month-plan rate, not a standing monthly price, and the number that applies after that is disclosed only after intake. If you want a provider that publishes its ongoing rate up front, compare it against Sunlight or bmiMD. For a provider whose headline price this review found was even more misleading, see WeightRx. See our best tirzepatide providers ranking for the full field.